169 related articles for article (PubMed ID: 27019964)
1. Tailored Antibiotic Combination Powders for Inhaled Rotational Antibiotic Therapy.
Lee SH; Teo J; Heng D; Ng WK; Zhao Y; Tan RB
J Pharm Sci; 2016 Apr; 105(4):1501-12. PubMed ID: 27019964
[TBL] [Abstract][Full Text] [Related]
2. A novel inhaled multi-pronged attack against respiratory bacteria.
Lee SH; Teo J; Heng D; Zhao Y; Ng WK; Chan HK; Tan LT; Tan RB
Eur J Pharm Sci; 2015 Apr; 70():37-44. PubMed ID: 25612805
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria.
Wang J; Kutter JP; Mu H; Moodley A; Yang M
Int J Pharm; 2020 Nov; 590():119877. PubMed ID: 32927003
[TBL] [Abstract][Full Text] [Related]
4. Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections.
Mangal S; Huang J; Shetty N; Park H; Lin YW; Yu HH; Zemlyanov D; Velkov T; Li J; Zhou QT
Int J Pharm; 2019 Apr; 561():102-113. PubMed ID: 30797863
[TBL] [Abstract][Full Text] [Related]
5. Synergistic combination dry powders for inhaled antimicrobial therapy: formulation, characterization and in vitro evaluation.
Lee SH; Teo J; Heng D; Ng WK; Chan HK; Tan RB
Eur J Pharm Biopharm; 2013 Feb; 83(2):275-84. PubMed ID: 23010564
[TBL] [Abstract][Full Text] [Related]
6. Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.
Zhou QT; Sun SP; Chan JG; Wang P; Barraud N; Rice SA; Wang J; Li J; Chan HK
Mol Pharm; 2015 Aug; 12(8):2594-603. PubMed ID: 25423590
[TBL] [Abstract][Full Text] [Related]
7. Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections.
Lin Y; Chang RYK; Britton WJ; Morales S; Kutter E; Li J; Chan HK
Eur J Pharm Biopharm; 2019 Sep; 142():543-552. PubMed ID: 31398437
[TBL] [Abstract][Full Text] [Related]
8. The Delivery of High-Dose Dry Powder Antibiotics by a Low-Cost Generic Inhaler.
Parumasivam T; Leung SS; Tang P; Mauro C; Britton W; Chan HK
AAPS J; 2017 Jan; 19(1):191-202. PubMed ID: 27679516
[TBL] [Abstract][Full Text] [Related]
9. Effects of Surface Composition on the Aerosolisation and Dissolution of Inhaled Antibiotic Combination Powders Consisting of Colistin and Rifampicin.
Wang W; Zhou QT; Sun SP; Denman JA; Gengenbach TR; Barraud N; Rice SA; Li J; Yang M; Chan HK
AAPS J; 2016 Mar; 18(2):372-84. PubMed ID: 26603890
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
Li X; Vogt FG; Hayes D; Mansour HM
Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
[TBL] [Abstract][Full Text] [Related]
11. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
Yu H; Teo J; Chew JW; Hadinoto K
Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148
[TBL] [Abstract][Full Text] [Related]
12. Steroid-decorated antibiotic microparticles for inhaled anti-infective therapy.
Lee SH; Teo J; Heng D; Zhao Y; Ng WK; Chan HK; Tan RB
J Pharm Sci; 2014 Apr; 103(4):1115-25. PubMed ID: 24510431
[TBL] [Abstract][Full Text] [Related]
13. Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.
Zhou QT; Morton DA; Yu HH; Jacob J; Wang J; Li J; Chan HK
J Pharm Sci; 2013 Oct; 102(10):3736-47. PubMed ID: 23904207
[TBL] [Abstract][Full Text] [Related]
14. Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis.
Shao Z; Tam KK; Achalla VPK; Woon ECY; Mason AJ; Chow SF; Yam WC; Lam JKW
Int J Pharm; 2024 Apr; 654():123960. PubMed ID: 38447778
[TBL] [Abstract][Full Text] [Related]
15. Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.
Momin MAM; Tucker IG; Doyle CS; Denman JA; Sinha S; Das SC
Int J Pharm; 2018 Apr; 541(1-2):26-36. PubMed ID: 29458207
[TBL] [Abstract][Full Text] [Related]
16. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
[TBL] [Abstract][Full Text] [Related]
17. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication.
Wang J; Guo Y; Lu W; Liu X; Zhang J; Sun J; Chai G
Int J Pharm; 2024 Jun; 658():124208. PubMed ID: 38723731
[TBL] [Abstract][Full Text] [Related]
18. Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis.
Kwok PC; Grabarek A; Chow MY; Lan Y; Li JC; Casettari L; Mason AJ; Lam JK
Int J Pharm; 2015 Aug; 491(1-2):367-74. PubMed ID: 26151107
[TBL] [Abstract][Full Text] [Related]
19. Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation.
Chang RYK; Chen K; Wang J; Wallin M; Britton W; Morales S; Kutter E; Li J; Chan HK
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158280
[TBL] [Abstract][Full Text] [Related]
20. Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections.
Yu S; Wang S; Zou P; Chai G; Lin YW; Velkov T; Li J; Pan W; Zhou QT
Int J Pharm; 2020 Feb; 575():118915. PubMed ID: 31816354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]